Once within the parenchyma, T cells must navigate a dense extracellular matrix (ECM), fibroblast and myeloid-mediated immunosuppression (e.g., via TGF-β), and aberrant vasculature to reach tumor cells, recognize them, and exert their cytotoxic effects [123,124,125]. This evidence concerns the gene TGFB1 and neoplasm.